John Sieckhaus - 30 Nov 2023 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Operating Officer
Signature
/s/ John Sieckhaus
Issuer symbol
BSGM
Transactions as of
30 Nov 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Dec 2023, 18:17:36 UTC
Date Of Original Report
04 Dec 2023
Previous filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Award $0 +92,300 +25% $0.000000 457,920 30 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock.
F2 The shares of restricted stock fully vested on November 30, 2023, the date of the grant.